FDA Questions Benefit of Amgen Bone Drug in Certain Cases - Wall Street Journal (blog)

USA TODAY

FDA Questions Benefit of Amgen Bone Drug in Certain Cases Wall Street Journal (blog) Amgen conducted a study of Xgeva in 1432 men with prostate cancer that had not responded to previous therapies, but had not spread to the bones. Many types of cancer spread to the bones and cause tumors to grow, destroying the bone around the tumor, ... FDA Skeptical of Amgen Drug Ahead of PanelTheStreet.com FDA Staff Questions Merit of Expanding Use of Amgen's XgevaBusinessWeek Amgen's Xgeva Spurs FDA to Question Whether Delaying Cancer Justifies UseBloomberg U.S. News & World Report -DailyFinance all 222 news articles »

Ask Dr. K: Hot flashes in men are caused by low testosterone - Greenville Daily Reflector

Ask Dr. K: Hot flashes in men are caused by low testosterone Greenville Daily Reflector Dear Dr. K: I'ma 75-year-old man who recently underwent prostate cancer surgery. I've begun to have what I think are hot flashes. I'm baffled, because I thought hot flashes were a female problem. Could I be having male hot flashes? and more »